| Quarter | Score |
|---|---|
| 2022-Q1 | 50.7 |
| 2022-Q2 | 49.8 |
| 2022-Q3 | 45.4 |
| 2022-Q4 | 51.8 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 46.1 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 65.5 |
| 2024-Q1 | 70.0 |
| 2024-Q2 | 41.1 |
| 2024-Q3 | 78.8 |
| 2024-Q4 | 77.9 |
| 2025-Q1 | 80.6 |
| 2025-Q2 | 78.9 |
| 2025-Q3 | 78.2 |
| 2025-Q4 | 83.5 |
| 2026-Q1 | 79.4 |
| 2026-Q2 | 78.9 |
Funds reducing exposure or consensus momentum fading
Trading 65.4% below funds' estimated purchase price
2 of 18 tracked funds hold CPRI. Avg conviction: 1.1%. Net trimming. First tracked at $42.44 (current -65.4% vs tracked).
Greenlight Capital has 2.3% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Greenlight Capital | 2.3% | Reduce |
| Citadel Advisors | 0.0% | Reduce |